Hydroa vacciniforme-like lymphoproliferative disorder
Clinical trials for Hydroa vacciniforme-like lymphoproliferative disorder explained in plain language.
Never miss a new study
Get alerted when new Hydroa vacciniforme-like lymphoproliferative disorder trials appear
Sign up with your email to follow new studies for Hydroa vacciniforme-like lymphoproliferative disorder, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood cancers: first human trial launches
Disease control Recruiting nowThis study tests a new drug called DR-01 in adults with rare types of leukemia or lymphoma. The goal is to see if it is safe and can shrink tumors. About 200 people will take part in this early-stage trial.
Matched conditions: HYDROA VACCINIFORME-LIKE LYMPHOPROLIFERATIVE DISORDER
Phase 1/2 • Sponsor: Dren Bio • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Massive T-Cell lymphoma database aims to unlock new insights
Knowledge-focused Recruiting nowThis study is creating a large database of information and tissue samples from 1,000 people with T-cell lymphoma. Researchers will use this data to learn more about the disease and how to improve patient outcomes. Participants provide medical information and optional blood and na…
Matched conditions: HYDROA VACCINIFORME-LIKE LYMPHOPROLIFERATIVE DISORDER
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC